Last reviewed · How we verify
of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCO
The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and dapagliflozin as monotherapies and the effect of both of them as a combined therapy in infertile women with PCOs.
Details
| Lead sponsor | Beni-Suef University |
|---|---|
| Phase | PHASE3 |
| Status | UNKNOWN |
| Enrolment | 200 |
| Start date | Sat Jan 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Jul 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- PCO
Interventions
- Dapagliflozin 5 MG
- Metformin Hydrochloride 1000 MG
- Dapagliflozin/Metformin
Countries
Egypt